Day One Biopharmaceuticals, Inc.
DAWNDelisted Apr 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001845337
Day One Biopharmaceuticals, Inc. was delisted on Apr 23, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 208 institutions reported holding it in 13F filings for Q1 2026, worth $1.85B in total; Soros Fund Management was the only superinvestor holding it.
Holders of 5% or more of DAWN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Day One Biopharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G | 5.80%5.85M shares | +1.10 ppfrom 4.70% | Apr 28, 20252 filings | Jul 17, 2025 | SEC |
| Glazer Capital, LLC | 13G | 5.40%5.62M shares | New | Mar 19, 20261 filing | Mar 19, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
44 Schedule 13D and 13G filings on Day One Biopharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 15, 20265:02 PM ET | Vestal Point Capital, LPand 1 other | 13G/A | 0.00%0 shares | −5.10 ppfrom 5.10%Below 5% | Mar 31, 2026 | SEC |
| May 14, 20264:19 PM ET | Atlas Venture Fund XI, L.P.and 8 others | 13G/A | 0.00%0 shares | –Below 5% | Mar 31, 2026 | SEC |
| Apr 27, 20265:55 PM ET | AI Day1 LLCand 3 others | 13D/A | 0.00%0 shares | −12.52 ppfrom 12.52%Below 5% | Apr 23, 2026 | SEC |
| Apr 13, 20265:06 PM ET | AI Day1 LLCand 3 others | 13D/A | 12.52%12.9M shares | – | Apr 9, 2026 | SEC |
| Apr 7, 20261:22 PM ET | FMR LLCand 1 other | 13G/A | 0.00%23.6K shares | −5.60 ppfrom 5.60%Below 5% | Mar 31, 2026 | SEC |
| Mar 26, 20265:42 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Mar 19, 20264:46 PM ET | Glazer Capital, LLCand 1 other | 13G | 5.40%5.62M shares | New | Mar 12, 2026 | SEC |
| Feb 17, 20264:06 PM ET | Vestal Point Capital, LPand 1 other | 13G | 5.10%5.20M shares | New | Dec 31, 2025 | SEC |
| Feb 5, 20261:20 PM ET | FMR LLCand 1 other | 13G/A | 5.60%5.72M shares | −4.30 ppfrom 9.90% | Dec 31, 2025 | SEC |
| Nov 5, 202511:30 AM ET | FMR LLCand 1 other | 13G/A | 9.90%10.1M shares | −1.30 ppfrom 11.20% | Sep 30, 2025 | SEC |
| Aug 14, 20256:00 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 0.00%0 shares | −5.70 ppfrom 5.70%Below 5% | Jun 30, 2025 | SEC |
| Aug 6, 202511:56 AM ET | FMR LLCand 1 other | 13G/A | 11.20%11.3M shares | −1.60 ppfrom 12.80% | Jun 30, 2025 | SEC |
| Jul 17, 20257:54 PM ET | BlackRock, Inc. | 13G | 5.80%5.85M shares | +1.10 ppfrom 4.70% | Jun 30, 2025 | SEC |
| Apr 28, 20255:45 PM ET | BlackRock, Inc. | 13G/A | 4.70%4.81M shares | –Below 5% | Mar 31, 2025 | SEC |
| Feb 14, 20256:31 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 5.70%5.76M shares | – | Dec 31, 2024 | SEC |
| Feb 12, 20259:28 AM ET | FMR LLCand 1 other | 13G/A | 12.80%12.9M shares | – | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Atlas Venture Fund XI, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 7, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Nov 7, 2024 | FMR LLC | 13GOld format | – | – | – | SEC |
| Aug 5, 2024 | AI Day1 LLC | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Feb 9, 2024 | Atlas Venture Fund XI, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jan 29, 20245:25 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Oct 20, 2023 | AI Day1 LLC | 13D/AOld format | – | – | – | SEC |
| Aug 10, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jun 12, 2023 | AI Day1 LLC | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Atlas Venture Fund XI, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 3, 2023 | Takeda Pharmaceutical Co Ltd | 13G/AOld format | – | – | – | SEC |
| Nov 2, 2022 | Canaan XI L.P. | 13D/AOld format | – | – | – | SEC |
| Oct 19, 2022 | Canaan XI L.P. | 13D/AOld format | – | – | – | SEC |
| Sep 22, 2022 | Canaan XI L.P. | 13D/AOld format | – | – | – | SEC |
| Sep 19, 2022 | Canaan XI L.P. | 13D/AOld format | – | – | – | SEC |
| Sep 12, 2022 | FMR LLC | 13GOld format | – | New | – | SEC |
| Jun 21, 2022 | AI Day1 LLC | 13D/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Atlas Venture Fund XI, L.P. | 13GOld format | – | New | – | SEC |
| Jan 14, 2022 | Takeda Pharmaceutical Co Ltd | 13GOld format | – | New | – | SEC |
| Dec 22, 2021 | Canaan XI L.P. | 13D/AOld format | – | – | – | SEC |
| Jun 10, 2021 | Canaan XI L.P. | 13DOld format | – | New | – | SEC |
| Jun 9, 2021 | AI Day1 LLC | 13DOld format | – | New | – | SEC |
| Jun 7, 2021 | Ra Capital Management, L.P. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
39 notices from officers, directors and other affiliates planning to sell Day One Biopharmaceuticals, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 20266:21 PM ET | Jeremy BenderOfficer · Director | 15.5K | $179.3K | Feb 17, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 17, 20266:18 PM ET | Charles YorkOfficer | 6.07K | $70.4K | Feb 17, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 17, 20266:13 PM ET | Lauren MerendinoOfficer | 5.81K | $67.4K | Feb 17, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 17, 20266:08 PM ET | Adam DubowOfficer | 6.39K | $74.2K | Feb 17, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 17, 20254:12 PM ET | Charles YorkOfficer | 4.06K | $36.2K | Nov 17, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 17, 20254:12 PM ET | Lauren MerendinoOfficer | 3.73K | $33.2K | Nov 17, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 17, 20254:11 PM ET | Adam DubowOfficer | 4.32K | $38.5K | Nov 17, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 17, 20254:09 PM ET | Jeremy BenderOfficer · Director | 15.9K | $141.7K | Nov 17, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 18, 20255:33 PM ET | Jeremy BenderOfficer · Director | 16.1K | $108.7K | Aug 18, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 16, 20254:09 PM ET | Charles YorkOfficer | 4.28K | $26.8K | May 16, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 16, 20254:09 PM ET | Lauren MerendinoOfficer | 3.93K | $24.6K | May 16, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 16, 20254:08 PM ET | Adam DubowOfficer | 4.55K | $28.5K | May 16, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 16, 20254:08 PM ET | Jeremy BenderOfficer · Director | 14.0K | $87.4K | May 16, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 18, 20256:07 PM ET | Adam DubowOfficer | 4.65K | $55.6K | Feb 18, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 18, 20256:04 PM ET | Charles YorkOfficer | 4.37K | $52.3K | Feb 18, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 18, 20256:02 PM ET | Jeremy BenderOfficer · Director | 12.0K | $144.1K | Feb 18, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 18, 20244:22 PM ET | Samuel BlackmanOfficer | 2.21K | $29.1K | Nov 18, 2024 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 18, 20244:21 PM ET | Jeremy BenderOfficer · Director | 10.6K | $139.4K | Nov 18, 2024 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 12, 20247:49 AM ET | Samuel BlackmanOfficer | 50.0K | $819.5K | Nov 11, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Oct 31, 20244:27 PM ET | Samuel BlackmanOfficer | 30.0K | $434.1K | Oct 31, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 16, 20245:23 PM ET | Jeremy BenderOfficer · Director | 10.7K | $149.5K | Aug 16, 2024 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 16, 20245:17 PM ET | Samuel BlackmanOfficer | 2.23K | $31.2K | Aug 16, 2024 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jul 16, 20244:32 PM ET | Samuel BlackmanOfficer | 80.0K | $1.26M | Jul 16, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 21, 20244:14 PM ET | Saira RamasastryDirector | 10.0K | $131.9K | Jun 21, 2024 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 10, 20244:58 PM ET | Samuel BlackmanOfficer | 30.0K | $383.1K | Jun 10, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
Showing the latest 25. See the DAWN notices from the last 12 months